Your browser doesn't support javascript.
loading
A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Shouse, Geoffrey; Chen, Lu; Siddiqi, Tanya; Muir, Alex; Brown, Jennifer R; Spurgeon, Stephen E; Danilov, Alexey V.
Afiliación
  • Shouse G; City of Hope National Medical Center, CA, USA.
  • Chen L; City of Hope National Medical Center, CA, USA.
  • Siddiqi T; City of Hope National Medical Center, CA, USA.
  • Muir A; City of Hope National Medical Center, CA, USA.
  • Brown JR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Spurgeon SE; The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Danilov AV; City of Hope National Medical Center, CA, USA.
Leuk Lymphoma ; 65(10): 1516-1519, 2024 Oct.
Article en En | MEDLINE | ID: mdl-38836342

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azetidinas / Leucemia Linfocítica Crónica de Células B Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Azetidinas / Leucemia Linfocítica Crónica de Células B Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos